We experimentally confirmed the capture and release of intact CD63-GFP+ EVs produced in large amounts by our LM-3475 cells in vitro prior to purifying low abundance (i.e., compared to tissue culture) human tumor-derived EVs from the EBC of lung tumor-bearing mice. This evidence concerns the gene CD63 and neoplasm.